Heron Therapeutics
HRTX
#7834
Rank
$0.24 B
Marketcap
$1.58
Share price
3.27%
Change (1 day)
-11.73%
Change (1 year)

EPS for Heron Therapeutics (HRTX)

EPS in 2023 (TTM): -$1.17

According to Heron Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.17. In 2022 the company made an earnings per share (EPS) of -$1.73 an increase over its 2021 EPS that were of -$2.25.

EPS history for Heron Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.17-32.37%
2022-$1.73-23.11%
2021-$2.25-10%
2020-$2.50-0%
2019-$2.501.21%
2018-$2.47-32.7%
2017-$3.67-19.34%
2016-$4.5554.76%
2015-$2.941.73%
2014-$2.89-16.23%
2013-$3.4591.67%
2012-$1.80-31.45%
2011-$2.63-27.06%
2010-$3.60-43.75%
2009-$6.40-57.33%
2008-$15.00-82.92%
2007-$87.8020.61%
2006-$72.80175.76%
2005-$26.40-21.43%
2004-$33.60100%
2003-$16.80-38.24%
2002-$27.20161.54%
2001-$10.40-106.46%
2000$160.902051.55%
1999$7.48839.73%
1998$0.80-105.48%
1997-$14.53-88.16%
1996-$122.74

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$1.30-211.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$0.14-111.97%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.63 39.32%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.57-234.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.65 41.03%๐Ÿ‡บ๐Ÿ‡ธ USA